Arq. Bras. Oftalmol. 2024; 87 (3): 10.5935/0004-2749.2022-0010
Total: 2683
Oscar Andree García Ruiz1; Julio José González-López2
DOI: 10.5935/0004-2749.2022-0010
1. Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain
2. Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain. Orcid
Julio José González-López
E-mail: [email protected]
Funding: This study received no specific financial support
Conflicts of interest: JJGL has been co-investigator for Hoffmann-La Roche AG, holds stock of Gilead, and has received study grants from Alcon, Allergan, Brill and Théa
Informed consent was obtained from the patient included in this study
How to cite this article: